Analyst Makes The Case For Ligand As A 'Core' Holding

Analysts at H.C. Wainwright & Co. continue to see
Ligand Pharmaceuticals Inc.LGND
as a "core long term holding" for investors. The firm's
Joseph Pantginis
initiated coverage of the biopharmaceutical company with a Buy rating and $150 price target, mostly due to the company's
business model.

Ligand seeks out value-based acquisitions of companies and technologies that have led to both current and anticipated revenue streams, Pantginis commented in his initiation note. This has also resulted in the company's reputation of reporting sustained profitability. Ligand is also an early pioneer of contingent value rights for its acquisitions, the analyst continued. As such, earnings growth is supported by the company's increasing royalty streams that are also a "significant spreading out of risk" across multiple assets. On top of that, the reduced risk profile offers protection against downside to the stock on negative news relative to a typical biotechnology company. Related Links: 25 Stocks Moving In Tuesday's Pre-Market Session A Peek Into The Markets: U.S. Stock Futures Drop Ahead Of Fed Speakers

The company's management team also adds to the bullish story, Pantginis added. Specifically, John Higgins has been with the company since 2007 at which point Ligand was burning through approximately $100 million per year. Since then the executive oversaw a streamlining of operations and reduced expenses to approximately $20 million per year.

Bottom line, Ligand's stock is appealing to investors that are both revenue and earnings minded and want exposure to the biotechnology drug development sector with risk spread out across various assets.

Posted In: Biotech StocksbiotechnologyHC WainwrightJoseph PantginisAnalyst ColorBiotechLong IdeasPrice TargetInitiationTop StoriesAnalyst RatingsTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.